In Vitro Activity of Rifampicin Combined with Daptomycin or Tigecycline on Staphylococcus haemolyticus Biofilms

Staphylococcus haemolyticus is of increasing concern as a cause of several biofilm-associated infections, and today, it represents the second most common organism among clinical isolates of coagulase-negative staphylococci. However, little is known regarding the treatment of infections caused by the...

Descripción completa

Detalles Bibliográficos
Autores principales: Szczuka, Ewa, Grabska, Katarzyna, Kaznowski, Adam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486112/
https://www.ncbi.nlm.nih.gov/pubmed/25894996
http://dx.doi.org/10.1007/s00284-015-0821-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486112/
https://www.ncbi.nlm.nih.gov/pubmed/25894996
http://dx.doi.org/10.1007/s00284-015-0821-y

Ejemplares similares